Advertisement
Screener

Q Therapeutics, Inc. Research and Development Expense

Q Therapeutics, Inc. Research and Development Expense

Q Therapeutics, Inc. reported Research and Development Expense of $243.05 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2015-11-13

  • Q Therapeutics, Inc. research and development expense for the quarter ending 2015-09-30 was $243.05K, a 35.18% decline year-over-year.
  • Q Therapeutics, Inc. research and development expense for the quarter ending 2015-06-30 was $261.02K, a 66.66% decline year-over-year.
  • Q Therapeutics, Inc. research and development expense for the quarter ending 2015-03-31 was $227.16K, a 53.08% decline year-over-year.
  • Q Therapeutics, Inc. research and development expense for the quarter ending 2014-12-31 was $318.79K, a 72.37% increase year-over-year.
  • Q Therapeutics, Inc. research and development expense for fiscal 2014 was $1.96M, a 7.29% increase from fiscal 2013.
  • Q Therapeutics, Inc. research and development expense for fiscal 2013 was $1.83M, a 12.53% decline from fiscal 2012.
  • Q Therapeutics, Inc. research and development expense for fiscal 2012 was $2.09M, a 369.69% increase from fiscal 2011.
  • Q Therapeutics, Inc. research and development expense for fiscal 2011 was $444.83K, a 11.37% decline from fiscal 2010.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 117 monthResearch and Development Expense 120 monthResearch and Development Expense 123 monthResearch and Development Expense 126 monthResearch and Development Expense 129 monthResearch and Development Expense 132 monthResearch and Development Expense 135 monthResearch and Development Expense 138 monthResearch and Development Expense 141 monthResearch and Development Expense 144 month
2015-09-30$243.05K
10-Q · filed 2015-11-13
$504.08K
derived: sum of 2 quarters · filed 2015-11-13
$731.23K
10-Q · filed 2015-11-13
$1.05M
derived: sum of 4 quarters · filed 2015-11-13
2015-06-30$261.02K
10-Q · filed 2015-08-14
$488.18K
10-Q · filed 2015-08-14
$806.97K
derived: sum of 3 quarters · filed 2015-08-14
$1.18M
derived: sum of 4 quarters · filed 2015-11-13
2015-03-31$227.16K
10-Q · filed 2015-05-11
$545.95K
derived: sum of 2 quarters · filed 2015-05-11
$920.89K
derived: sum of 3 quarters · filed 2015-11-13
$1.70M
derived: sum of 4 quarters · filed 2015-11-13
2014-12-31$318.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$693.73K
derived: sum of 2 quarters · filed 2015-11-13
$1.48M
derived: sum of 3 quarters · filed 2015-11-13
$1.96M
10-K · filed 2015-03-31
2014-09-30$374.94K
10-Q · filed 2015-11-13
$1.16M
derived: sum of 2 quarters · filed 2015-11-13
$1.64M
10-Q · filed 2015-11-13
$1.83M
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$782.94K
10-Q · filed 2015-08-14
$1.27M
10-Q · filed 2015-08-14
$1.45M
derived: sum of 3 quarters · filed 2015-08-14
$2.82M
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$484.14K
10-Q · filed 2015-05-11
$669.09K
derived: sum of 2 quarters · filed 2015-05-11
$2.04M
derived: sum of 3 quarters · filed 2015-05-11
$2.18M
derived: sum of 4 quarters · filed 2015-05-11
$13.28M
10-Q · filed 2014-05-15
2013-12-31$184.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$1.56M
derived: sum of 2 quarters · filed 2015-03-31
$1.70M
derived: sum of 3 quarters · filed 2015-03-31
$1.83M
10-K · filed 2015-03-31
$12.80M
10-K · filed 2014-04-15
2013-09-30$1.37M
10-Q · filed 2014-11-07
$1.51M
derived: sum of 2 quarters · filed 2014-11-07
$1.64M
10-Q · filed 2014-11-07
$2.97M
derived: sum of 4 quarters · filed 2014-11-07
$12.62M
10-Q · filed 2013-11-14
2013-06-30$139.84K
10-Q · filed 2014-07-31
$270.95K
10-Q · filed 2014-07-31
$1.60M
derived: sum of 3 quarters · filed 2014-07-31
$1.88M
derived: sum of 4 quarters · filed 2014-07-31
$11.24M
10-Q · filed 2013-08-13
2013-03-31$131.11K
10-Q · filed 2014-05-15
$1.46M
derived: sum of 2 quarters · filed 2014-05-15
$1.74M
derived: sum of 3 quarters · filed 2014-05-15
$2.00M
derived: sum of 4 quarters · filed 2014-05-15
$11.10M
10-Q · filed 2013-05-03
2012-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15
$1.61M
derived: sum of 2 quarters · filed 2014-04-15
$1.87M
derived: sum of 3 quarters · filed 2014-04-15
$2.09M
10-K · filed 2014-04-15
$10.97M
10-K · filed 2013-03-28
2012-09-30$283.14K
10-Q · filed 2013-11-14
$540.60K
derived: sum of 2 quarters · filed 2013-11-14
$764.81K
10-Q · filed 2013-11-14
$922.91K
derived: sum of 4 quarters · filed 2013-11-14
$9.65M
10-Q · filed 2012-11-13
2012-06-30$257.46K
10-Q · filed 2013-08-13
$481.67K
10-Q · filed 2013-08-13
$639.76K
derived: sum of 3 quarters · filed 2013-08-13
$649.07K
derived: sum of 4 quarters · filed 2013-08-13
$9.37M
10-Q/A · filed 2012-09-10
2012-03-31$224.21K
10-Q · filed 2013-05-03
$382.30K
derived: sum of 2 quarters · filed 2013-05-03
$391.61K
derived: sum of 3 quarters · filed 2013-05-03
$550.37K
derived: sum of 4 quarters · filed 2013-05-03
$9.11M
10-Q · filed 2012-05-16
2011-12-31$158.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$167.40K
derived: sum of 2 quarters · filed 2013-03-28
$326.17K
derived: sum of 3 quarters · filed 2013-03-28
$444.83K
10-K · filed 2013-03-28
$8.88M
10-K · filed 2012-03-23
2011-09-30$9.31K
10-Q · filed 2012-11-13
$168.07K
derived: sum of 2 quarters · filed 2012-11-13
$286.74K
10-Q · filed 2012-11-13
2011-06-30$158.76K
10-Q/A · filed 2012-09-10
$277.43K
10-Q/A · filed 2012-09-10
2011-03-31$118.67K
10-Q · filed 2012-05-16
2010-12-31$501.90K
10-K · filed 2012-03-23